These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1265 related items for PubMed ID: 26363555

  • 21. Priming but not boosting with plasmid DNA encoding mycolyl-transferase Ag85A from Mycobacterium tuberculosis increases the survival time of Mycobacterium bovis BCG vaccinated mice against low dose intravenous challenge with M. tuberculosis H37Rv.
    Romano M, D'Souza S, Adnet PY, Laali R, Jurion F, Palfliet K, Huygen K.
    Vaccine; 2006 Apr 12; 24(16):3353-64. PubMed ID: 16488518
    [Abstract] [Full Text] [Related]

  • 22. Immune responses and protective efficacy induced by 85B antigen and early secreted antigenic target-6 kDa antigen fusion protein secreted by recombinant bacille Calmette-Guérin.
    Shi C, Wang X, Zhang H, Xu Z, Li Y, Yuan L.
    Acta Biochim Biophys Sin (Shanghai); 2007 Apr 12; 39(4):290-6. PubMed ID: 17417685
    [Abstract] [Full Text] [Related]

  • 23. Comparison of BCG prime-DNA booster and rBCG regimens for protection against tuberculosis.
    Tan K, Liang J, Teng X, Wang X, Zhang J, Yuan X, Fan X.
    Hum Vaccin Immunother; 2014 Apr 12; 10(2):391-8. PubMed ID: 24192709
    [Abstract] [Full Text] [Related]

  • 24. Recombinant BCG prime and PPE protein boost provides potent protection against acute Mycobacterium tuberculosis infection in mice.
    Yang E, Gu J, Wang F, Wang H, Shen H, Chen ZW.
    Microb Pathog; 2016 Apr 12; 93():1-7. PubMed ID: 26792673
    [Abstract] [Full Text] [Related]

  • 25. Immunogenicity and protective efficacy of a tuberculosis DNA vaccine expressing a fusion protein of Ag85B-Esat6-HspX in mice.
    Yuan W, Dong N, Zhang L, Liu J, Lin S, Xiang Z, Qiao H, Tong W, Qin C.
    Vaccine; 2012 Mar 23; 30(14):2490-7. PubMed ID: 21704108
    [Abstract] [Full Text] [Related]

  • 26. Novel recombinant BCG coexpressing Ag85B, ESAT-6 and mouse TNF-alpha induces significantly enhanced cellular immune and antibody responses in C57BL/6 mice.
    Shen H, Wang C, Yang E, Xu Y, Liu W, Yan J, Wang F, Wang H.
    Microbiol Immunol; 2010 Aug 23; 54(8):435-41. PubMed ID: 20646207
    [Abstract] [Full Text] [Related]

  • 27. More vaccine efficacy studies on the recombinant Bacille Calmette-Guerin co-expressing Ag85B, Mpt64 and Mtb8.4.
    Qie YQ, Wang JL, Liu W, Shen H, Chen JZ, Zhu BD, Xu Y, Zhang XL, Wang HH.
    Scand J Immunol; 2009 Apr 23; 69(4):342-50. PubMed ID: 19284499
    [Abstract] [Full Text] [Related]

  • 28. Manipulation of BCG vaccine: a double-edged sword.
    Singh VK, Srivastava R, Srivastava BS.
    Eur J Clin Microbiol Infect Dis; 2016 Apr 23; 35(4):535-43. PubMed ID: 26810060
    [Abstract] [Full Text] [Related]

  • 29. MHC-restricted Ag85B-specific CD8+ T cells are enhanced by recombinant BCG prime and DNA boost immunization in mice.
    Komine-Aizawa S, Jiang J, Mizuno S, Hayakawa S, Matsuo K, Boyd LF, Margulies DH, Honda M.
    Eur J Immunol; 2019 Sep 23; 49(9):1399-1414. PubMed ID: 31135967
    [Abstract] [Full Text] [Related]

  • 30. Subunit vaccine candidate AMM down-regulated the regulatory T cells and enhanced the protective immunity of BCG on a suitable schedule.
    Luo Y, Jiang W, Da Z, Wang B, Hu L, Zhang Y, An R, Yu H, Sun H, Tang K, Tang Z, Wang Y, Jing T, Zhu B.
    Scand J Immunol; 2012 Mar 23; 75(3):293-300. PubMed ID: 22117839
    [Abstract] [Full Text] [Related]

  • 31. Protective efficacy of recombinant BCG over-expressing protective, stage-specific antigens of Mycobacterium tuberculosis.
    Counoupas C, Pinto R, Nagalingam G, Britton WJ, Triccas JA.
    Vaccine; 2018 May 03; 36(19):2619-2629. PubMed ID: 29627232
    [Abstract] [Full Text] [Related]

  • 32. Prime-boost vaccination with Bacillus Calmette Guerin and a recombinant adenovirus co-expressing CFP10, ESAT6, Ag85A and Ag85B of Mycobacterium tuberculosis induces robust antigen-specific immune responses in mice.
    Li W, Li M, Deng G, Zhao L, Liu X, Wang Y.
    Mol Med Rep; 2015 Aug 03; 12(2):3073-80. PubMed ID: 25962477
    [Abstract] [Full Text] [Related]

  • 33. Evaluation of immunogenicity and protective efficacy against Mycobacterium tuberculosis infection elicited by recombinant Mycobacterium bovis BCG expressing human Interleukin-12p70 and Early Secretory Antigen Target-6 fusion protein.
    Deng Y, Bao L, Yang X.
    Microbiol Immunol; 2011 Nov 03; 55(11):798-808. PubMed ID: 21831202
    [Abstract] [Full Text] [Related]

  • 34. Protection against Mycobacterium tuberculosis infection offered by a new multistage subunit vaccine correlates with increased number of IFN-γ+ IL-2+ CD4+ and IFN-γ+ CD8+ T cells.
    Wang X, Zhang J, Liang J, Zhang Y, Teng X, Yuan X, Fan X.
    PLoS One; 2015 Nov 03; 10(3):e0122560. PubMed ID: 25822536
    [Abstract] [Full Text] [Related]

  • 35. A recombinant adenovirus expressing CFP10, ESAT6, Ag85A and Ag85B of Mycobacterium tuberculosis elicits strong antigen-specific immune responses in mice.
    Li W, Deng G, Li M, Zeng J, Zhao L, Liu X, Wang Y.
    Mol Immunol; 2014 Nov 03; 62(1):86-95. PubMed ID: 24980867
    [Abstract] [Full Text] [Related]

  • 36. Gene-based neonatal immune priming potentiates a mucosal adenoviral vaccine encoding mycobacterial Ag85B.
    Dai G, Rady HF, Huang W, Shellito JE, Mason C, Ramsay AJ.
    Vaccine; 2016 Dec 07; 34(50):6267-6275. PubMed ID: 27823900
    [Abstract] [Full Text] [Related]

  • 37. Recombinant Mycobacterium bovis bacillus Calmette-Guérin expressing Ag85B-IL-7 fusion protein enhances IL-17A-producing innate γδ T cells.
    Hatano S, Tamura T, Umemura M, Matsuzaki G, Ohara N, Yoshikai Y.
    Vaccine; 2016 May 11; 34(22):2490-5. PubMed ID: 27079930
    [Abstract] [Full Text] [Related]

  • 38. Heterologous Boost Following Mycobacterium bovis BCG Reduces the Late Persistent, Rather Than the Early Stage of Intranasal Tuberculosis Challenge Infection.
    Wu Y, Cai M, Ma J, Teng X, Tian M, Bassuoney EBMB, Fan X.
    Front Immunol; 2018 May 11; 9():2439. PubMed ID: 30425711
    [Abstract] [Full Text] [Related]

  • 39. A new recombinant bacille Calmette-Guérin vaccine safely induces significantly enhanced tuberculosis-specific immunity in human volunteers.
    Hoft DF, Blazevic A, Abate G, Hanekom WA, Kaplan G, Soler JH, Weichold F, Geiter L, Sadoff JC, Horwitz MA.
    J Infect Dis; 2008 Nov 15; 198(10):1491-501. PubMed ID: 18808333
    [Abstract] [Full Text] [Related]

  • 40. Protection against tuberculosis induced by oral prime with Mycobacterium bovis BCG and intranasal subunit boost based on the vaccine candidate Ag85B-ESAT-6 does not correlate with circulating IFN-gamma producing T-cells.
    Badell E, Nicolle F, Clark S, Majlessi L, Boudou F, Martino A, Castello-Branco L, Leclerc C, Lewis DJ, Marsh PD, Gicquel B, Winter N.
    Vaccine; 2009 Jan 01; 27(1):28-37. PubMed ID: 18977269
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 64.